Mirror Biologics
Biotechnology, 3500 E Fletcher Ave Ste 425, Wesley Chapel, Florida, 33612, United States, 11-50 Employees
Phone Number: 95********
Who is MIRROR BIOLOGICS
Mirror Biologics is an international biopharmaceutical company headquartered in Tampa, Florida with operations in Jerusalem, Israel, Kuala Lumpur, Malaysia and Bangkok, Thailand. We are d...
Read More
-
Headquarters: 3500 E Fletcher Ave Ste 425, Wesley Chapel, Florida, 33612, United States
-
Date Founded: 2019
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
Scott Filosi
Email
Phone
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 325414 |
Show More
Does something look wrong? Fix it. | View contact records from MIRROR BIOLOGICS
Mirror Biologics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Mirror Biologics
Answer: Mirror Biologics's headquarters are located at 3500 E Fletcher Ave Ste 425, Wesley Chapel, Florida, 33612, United States
Answer: Mirror Biologics's phone number is 95********
Answer: Mirror Biologics's official website is https://mirrorbio.com
Answer: Mirror Biologics's revenue is $1 Million to $5 Million
Answer: Mirror Biologics's SIC: 2836
Answer: Mirror Biologics's NAICS: 325414
Answer: Mirror Biologics has 11-50 employees
Answer: Mirror Biologics is in Biotechnology
Answer: Mirror Biologics contact info: Phone number: 95******** Website: https://mirrorbio.com
Answer: Mirror Biologics is an international biopharmaceutical company headquartered in Tampa, Florida with operations in Jerusalem, Israel, Kuala Lumpur, Malaysia and Bangkok, Thailand. We are developing off-the-shelf, non-genetically manipulated, living immune cell therapies for metastatic solid tumors and as universal vaccine against respiratory viral infection in the elderly. In Tampa, we operate a 21 CFR 1271 registered blood donor center and conduct advanced bioreactor research and prototype development for commercial cell therapy manufacturing and also operate a clinical immunology lab for analysis of clinical samples. In Jerusalem we operate a GMP cell manufacturing and research facility. We also have clinical support and cold chain distribution operations in Bangkok, Thailand and Kuala Lumpur, Malaysia. The Mirror Effect technology platform enables reverse engineering of known effective immune responses and imprinting of these immune cascades upon failed immune systems. Mirror Effect technology is protected by over 200 patents issued worldwide. The lead drug, AlloStim, is a patented, disease-agnostic, allogeneic living immune cell differentiated from precursor cells purified from blood of healthy donors and formulated with monoclonal antibody-coated microparticles. The unique feature of AlloStim is that can imprint a protective or therapeutic cellular immune response that is customized to a patients resident disease without the need to have prior knowledge of the type of cancer/virus or genetic properties/antigenic structure of the disease. Proprietary artificial lymph node bioreactors are under development which are designed for high volume, high density scale-up of AlloStim. Novel frozen dosage forms enable extended shelf life and economical distribution. Mirror Biologics purchased the exclusive, worldwide rights to AlloStim and the Mirror Effect technology platform from Immunovative Therapies, Ltd, an Israeli company.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month